• Issue

    Annals of Clinical and Translational Neurology: Volume 8, Issue 3

    531-726
    March 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Open Access

Issue Information

  • Pages: 531-533
  • First Published: 11 March 2021

Research Articles

Open Access

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis

Roberta Magliozzi,  Marco Pitteri,  Stefano Ziccardi,  Anna Isabella Pisani,  Luigi Montibeller,  Damiano Marastoni,  Stefania Rossi,  Valentina Mazziotti,  Maddalena Guandalini,  Caterina Dapor,  Gianmarco Schiavi,  Agnese Tamanti,  Richard Nicholas,  Richard Reynolds,  Massimiliano Calabrese, 
  • Pages: 534-547
  • First Published: 23 January 2021
Open Access

Type I SMA “new natural history”: long-term data in nusinersen-treated patients

Marika Pane,  Giorgia Coratti,  Valeria A. Sansone,  Sonia Messina,  Michela Catteruccia,  Claudio Bruno,  Maria Sframeli,  Emilio Albamonte,  Marina Pedemonte,  Adele D’Amico,  Chiara Bravetti,  Beatrice Berti,  Concetta Palermo,  Daniela Leone,  Giorgia Brigati,  Paola Tacchetti,  Francesca Salmin,  Roberto De Sanctis,  Simona Lucibello,  Maria Carmela Pera,  Marco Piastra,  Orazio Genovese,  Enrico Bertini,  Gianluca Vita,  Francesco Danilo Tiziano,  Eugenio Mercuri,  the Italian EAP Working Group , 
  • Pages: 548-557
  • First Published: 06 February 2021
Open Access

HCMV infection and IFITM3 rs12252 are associated with Rasmussen's encephalitis disease progression

Yi-Song Wang,  Qiao-Li Luo,  Yu-Guang Guan,  Dong-Ying Fan,  Guo-Ming Luan,  An Jing, 
  • Pages: 558-570
  • First Published: 19 January 2021
Open Access

Clinical utility of anti-cytosolic 5’-nucleotidase 1A antibody in idiopathic inflammatory myopathies

Chiseko Ikenaga,  Andrew R. Findlay,  Namita A. Goyal,  Sarah Robinson,  Jonathan Cauchi,  Yessar Hussain,  Leo H. Wang,  Joshua C. Kershen,  Brent A. Beson,  Michael Wallendorf,  Robert C. Bucelli,  Tahseen Mozaffar,  Alan Pestronk,  Conrad C. Weihl, 
  • Pages: 571-578
  • First Published: 08 February 2021
Open Access

Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study

Karthick Natarajan,  Abbe Ullgren,  Behzad Khoshnood,  Charlotte Johansson,  José M. Laffita-Mesa,  Josef Pannee,  Henrik Zetterberg,  Kaj Blennow,  Caroline Graff, 
  • Pages: 579-591
  • First Published: 21 January 2021
Open Access

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants

Jing Yang,  Hao Wang,  Yanpeng Yuan,  Shiheng Fan,  Lanjun Li,  Chenyang Jiang,  Chengyuan Mao,  Changhe Shi,  Yuming Xu, 
  • Pages: 592-602
  • First Published: 01 February 2021
Open Access

Isradipine plasma pharmacokinetics and exposure–response in early Parkinson’s disease

Charles S. Venuto,  Luoying Yang,  Monica Javidnia,  David Oakes,  D. James Surmeier,  Tanya Simuni, 
  • Pages: 603-612
  • First Published: 18 January 2021
Open Access

Deep brain stimulation effects on verbal fluency dissociated by target and active contact location

Kevin D. John,  Scott A. Wylie,  Benoit M. Dawant,  William J. Rodriguez,  Fenna T. Phibbs,  Elise B. Bradley,  Joseph S. Neimat,  Nelleke C. van Wouwe, 
  • Pages: 613-622
  • First Published: 17 February 2021
Open Access

Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization

Nicola De Stefano,  Antonio Giorgio,  Giordano Gentile,  Maria Laura Stromillo,  Rosa Cortese,  Claudio Gasperini,  Andrea Visconti,  Maria Pia Sormani,  Marco Battaglini, 
  • Pages: 623-630
  • First Published: 03 February 2021
Open Access

Serum neurofilament levels and patient-reported outcomes in multiple sclerosis

Kristin Galetta,  Chinmay Deshpande,  Brian C. Healy,  Bonnie Glanz,  Marina Ziehn,  Shrishti Saxena,  Anu Paul,  Fermisk Saleh,  Mikaela Collins,  Patricia Gaitan-Walsh,  Paola Castro-Mendoza,  Howard L. Weiner,  Tanuja Chitnis, 
  • Pages: 631-638
  • First Published: 25 January 2021
Open Access

Ataluren for drug-resistant epilepsy in nonsense variant-mediated Dravet syndrome and CDKL5 deficiency disorder

Orrin Devinsky,  LaToya King,  Judith Bluvstein,  Daniel Friedman, 
  • Pages: 639-644
  • First Published: 04 February 2021
Open Access

Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome

Asako Horino,  Ichiro Kuki,  Takeshi Inoue,  Megumi Nukui,  Shin Okazaki,  Hisashi Kawawaki,  Masao Togawa,  Kiyoko Amo,  Junichi Ishikawa,  Atsushi Ujiro,  Masashi Shiomi,  Hiroshi Sakuma, 
  • Pages: 645-655
  • First Published: 05 February 2021
Open Access

Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis

Gregorio Spagni,  Laura Todi,  Gabriele Monte,  Mariagrazia Valentini,  Gabriele Di Sante,  Valentina Damato,  Mariapaola Marino,  Amelia Evoli,  Francesca Lantieri,  Carlo Provenzano, 
  • Pages: 656-665
  • First Published: 05 February 2021
Open Access

KCNQ2-DEE: developmental or epileptic encephalopathy?

Anne T. Berg,  Sonal Mahida,  Annapurna Poduri, 
  • Pages: 666-676
  • First Published: 22 February 2021
Open Access

Mitochondrial morphology and MAVS-IFN1 signaling pathway in muscles of anti-MDA5 dermatomyositis

Yanyan Jiang,  Yilin Liu,  Yawen Zhao,  Yiming Zheng,  Meng Yu,  Jianwen Deng,  Hongjun Hao,  Wei Zhang,  Zhaoxia Wang,  Yun Yuan, 
  • Pages: 677-686
  • First Published: 12 February 2021
Open Access

Angiopoietin-like protein 4 and clinical outcomes in ischemic stroke patients

Xiaowei Zheng,  Suwen Shen,  Aili Wang,  Zhengbao Zhu,  Yanbo Peng,  Hao Peng,  Chongke Zhong,  Daoxia Guo,  Tan Xu,  Jing Chen,  Zhong Ju,  Deqin Geng,  Yonghong Zhang,  Jiang He, 
  • Pages: 687-695
  • First Published: 22 February 2021

Brief Communications

Open Access

Improving risk-stratification of natalizumab-associated PML

Bastian Tugemann,  Joseph R. Berger, 
  • Pages: 696-703
  • First Published: 04 February 2021
Open Access

Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy

Laura Licchetta,  Lorenzo Ferri,  Chiara La Morgia,  Corrado Zenesini,  Leonardo Caporali,  Maria Lucia Valentino,  Raffaella Minardi,  Daniela Fulitano,  Lidia Di Vito,  Barbara Mostacci,  Lara Alvisi,  Patrizia Avoni,  Rocco Liguori,  Paolo Tinuper,  Francesca Bisulli,  Valerio Carelli, 
  • Pages: 704-710
  • First Published: 21 January 2021
Open Access

Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial

Robert A. Bermel,  Emmanuelle Waubant,  Gabriel Pardo,  Ann Bass,  Pavle Repovic,  Scott Newsome,  John W. Lindsey,  Deidre Kile,  Ashish Pradhan,  Bruno Musch,  Aram Zabeti, 
  • Pages: 711-715
  • First Published: 23 February 2021

Case Study

Open Access

Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings

Christopher M. McGraw,  Sonal Mahida,  Parul Jayakar,  Hyun Yong Koh,  Alan Taylor,  Trevor Resnick,  Lance Rodan,  Marc A. Schwartz,  Ayesha Ejaz,  Vijay G. Sankaran,  Gerard Berry,  Annapurna Poduri, 
  • Pages: 716-722
  • First Published: 26 January 2021

Letter

Open Access

COVID-19 encephalopathy, Bayes rule, and a plea for case–control studies

Esther Arbona-Haddad,  Ivo W. Tremont-Lukats,  Bhanu Gogia,  Prashant K. Rai,  for the Bayesian Neurology Group-Texas (BNG-TX) , 
  • Pages: 723-725
  • First Published: 29 January 2021

Reply To Letter

Open Access

Reply to COVID-19 encephalopathy, Bayes rule, and a plea for case–control studies

Eric M. Liotta,  Ayush Batra,  Igor J. Koralnik, 
  • Page: 726
  • First Published: 29 January 2021